The function of apolipoproteins L

Cellular and Molecular Life Sciences

Volumn 63, Issue 17, 2006, Pages 1937-1944

  Vanhollebeke, B ^a   Pays, E ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Apolipoprotein L (apoL); Innate immunity; Lysosome; Programmed cell death; Trypanosoma brucei

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN L; PROTEIN BCL 2; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; APOPTOSIS; CELL; CELL ACTIVITY; LIPID METABOLISM; LIPID TRANSPORT; LYSOSOME; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METABOLISM; REVIEW; TRYPANOSOMA;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; APOLIPOPROTEINS; APOPTOSIS; HUMANS; IMMUNITY, NATURAL; ION CHANNELS; LIPOPROTEINS, HDL; LYSOSOMES; MOLECULAR SEQUENCE DATA; MULTIGENE FAMILY; PROTO-ONCOGENE PROTEINS C-BCL-2; SEQUENCE HOMOLOGY, AMINO ACID; TRYPANOSOMA BRUCEI BRUCEI;

TRYPANOSOMA BRUCEI;

EID: 33748487618     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-006-6091-x     Document Type: Review

References (58)

1. Duchateau, P. N., Pullinger, C. R., Orellana, R. E., Kunitake, S. T., Naya-Vigne, J., O'Connor, P. M., Malloy, M. J. and Kane, J. P. (1997) Apolipoprotein L, a new human high density lipoprotein apolipoprotein expressed by the pancreas. Identification, cloning, characterization, and plasma distribution of apolipoprotein L. J. Biol. Chem. 272, 25576-25582.
2. Duchateau, P. N., Pullinger, C. R., Cho, M. H., Eng, C. and Kane, J. P. (2001) Apolipoprotein L gene family: tissue-specific expression, splicing, promoter regions; discovery of a new gene. J. Lipid Res. 42, 620-630.
3. Page, N. M., Butlin, D. J., Lomthaisong, K. and Lowry, P. J. (2001) The human apolipoprotein L gene cluster: identification, classification, and sites of distribution. Genomics 74, 71-78.
4. Duchateau, P. N., Movsesyan, I., Yamashita, S., Sakai, N., Hirano, K., Schoenhaus, S. A., O'Connor-Kearns, P. M., Spencer, S. J., Jaffe, R. B., Redberg, R. F., Ishida, B. Y., Matsuzawa, Y., Kane, J. P. and Malloy, M. J. (2000) Plasma apolipoprotein L concentrations correlate with plasma triglycerides and cholesterol levels in normolipidemic, hyperlipidemic, and diabetic subjects. J. Lipid Res. 41, 1231-1236.
5. Albert, T. S., Duchateau, P. N., Deeb, S. S., Pullinger, C. R., Cho, M. H., Heilbron, D. C., Malloy, M. J., Kane, J. P. and Brown, B. G. (2005) Apolipoprotein L-I is positively associated with hyperglycemia and plasma triglycerides in CAD patients with low HDL. J. Lipid Res. 46, 469-474.
6. Vanhamme, L., Paturiaux-Hanocq, F., Poelvoorde, P., Nolan, D. P., Lins, L., Van Den Abbeele, J., Pays, A., Tebabi, P., Van Xong, H., Jacquet, A., Moguilevsky, N., Dieu, M., Kane, J. P., De Baetselier, P., Brasseur, R. and Pays, E. (2003) Apolipoprotein L-I is the trypanosome lytic factor of human serum. Nature 422, 83-87.
7. Perez-Morga, D., Vanhollebeke, B., Paturiaux-Hanocq, F., Nolan, D. P., Lins, L., Homble, F., Vanhamme, L., Tebabi, P., Pays, A., Poelvoorde, P., Jacquet, A., Brasseur, R. and Pays, E. (2005) Apolipoprotein L-I promotes trypanosome lysis by forming pores in lysosomal membranes. Science 309, 469-472.
8. Green, H. P., Del Pilar Molina Portela, M., St Jean, E. N., Lugli, E. B. and Raper, J. (2003) Evidence for a Trypanosoma brucei lipoprotein scavenger receptor. J. Biol. Chem. 278, 422-427.
9. Poelvoorde, P., Vanhamme, L., Van Den Abbeele, J., Switzer, W. M. and Pays, E. (2004) Distribution of apolipoprotein L-I and trypanosome lytic activity among primate sera. Mol. Biochem. Parasitol. 134, 155-157.
10. Lugli, E. B., Pouliot, M., Portela Mdel, P., Loomis, M. R. and Raper, J. (2004) Characterization of primate trypanosome lytic factors. Mol. Biochem. Parasitol. 138, 9-20.
11. Monajemi, H., Fontijn, R. D., Pannekoek, H. and Horrevoets, A. J. (2002) The apolipoprotein L gene cluster has emerged recently in evolution and is expressed in human vascular tissue. Genomics 79, 539-546.
12. Regard, J. B., Scheck, S., Borbiev, T., Lanahan, A. A., Schneider, A., Demetriades, A. M., Hiemisch, H., Barnes, C. A., Verin, A. D. and Worley, P. F. (2004) Verge: a novel vascular early response gene. J. Neurosci. 24, 4092-4103.
13. Jentsch, T. J., Neagoe, I. and Scheel, O. (2005) CLC chloride channels and transporters. Curr. Opin. Neurobiol. 15, 319-325.
14. Riedl, S. J. and Shi, Y. (2004) Molecular mechanisms of caspase regulation during apoptosis. Nat. Rev. Mol. Cell Biol. 5, 897-907.
15. Ferri, K. F. and Kroemer, G. (2001) Organelle-specific initiation of cell death pathways. Nat. Cell Biol. 3, E255-E263.
16. Gross, A., McDonnell, J. M. and Korsmeyer, S. J. (1999) BCL-2 family members and the mitochondria in apoptosis. Genes Dev. 13, 1899-1911.
17. Aouacheria, A., Brunet, F. and Gouy, M. (2005) Phylogenomics of life-or-death switches in multicellular animals: Bcl-2, BH3-Only, and BNip families of apoptotic regulators. Mol. Biol. Evol. 22, 2395-2416.
18. Bouillet, P. and Strasser, A. (2002) BH3-only proteins - evolutionarily conserved proapoptotic Bcl-2 family members essential for initiating programmed cell death. J. Cell Sci. 115, 1567-1574.
19. Muchmore, S. W., Sattler, M., Liang, H., Meadows, R. P., Harlan, J. E., Yoon, H. S., Nettesheim, D., Chang, B. S., Thompson, C. B., Wong, S. L., Ng, S. L. and Fesik, S. W. (1996) X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature 381, 335-341.
20. Schendel, S. L., Azimov, R., Pawlowski, K., Godzik, A., Kagan, B. L. and Reed, J. C. (1999) Ion channel activity of the BH3 only Bcl-2 family member, BID. J. Biol. Chem. 274, 21932-21936.
21. Antonsson, B., Conti, F., Ciavatta, A., Montessuit, S., Lewis, S., Martinou, I., Bernasconi, L., Bernard, A., Mermod, J. J., Mazzei, G., Maundrell, K., Gambale, F., Sadoul, R. and Martinou, J. C. (1997) Inhibition of Bax channel-forming activity by Bcl-2. Science 277, 370-372.
22. Schendel, S. L., Xie, Z., Montal, M. O., Matsuyama, S., Montal, M. and Reed, J. C. (1997) Channel formation by antiapoptotic protein Bcl-2. Proc. Natl. Acad. Sci. USA 94, 5113-5118.
23. Minn, A. J., Velez, P., Schendel, S. L., Liang, H., Muchmore, S. W., Fesik, S. W., Fill, M. and Thompson, C. B. (1997) Bcl-x(L) forms an ion channel in synthetic lipid membranes. Nature 385, 353-357.
24. Sato, T., Hanada, M., Bodrug, S., Irie, S., Iwama, N., Boise, L. H., Thompson C. B., Golemis, E., Fong L., Wang, H. G., Reed, J. C. (1994) Interactions among members of the bcl-2 protein family analysed with yeast two-hybrid system. Proc. Natl. Acad. Sci. USA 91, 9238-9242.
25. Asoh, S., Nishimaki, K., Nanbu-Wakao, R. and Ohta, S. (1998) A trace amount of the human pro-apoptotic factor Bax induces bacterial death accompanied by damage of DNA. J. Biol. Chem. 273, 11384-11391.
26. Jin, C. and Reed, J. C. (2002) Yeast and apoptosis. Nat. Rev. Mol. Cell Biol. 3, 453-459.
27. Liu, Z., Lu, H., Jiang, Z., Pastuszyn, A. and Hu, C. A. (2005) Apolipoprotein L6, a novel proapoptotic Bcl-2 homology 3-only protein, induces mitochondria-mediated apoptosis in cancer cells. Mol. Cancer Res. 3, 21-31.
28. Ahn, W. S., Bae, S. M., Lee, J. M., Namkoong, S. E., Han, S. J., Cho, Y. L., Nam, G. H., Seo, J. S., Kim, C. K. and Kim, Y. W. (2004) Searching for pathogenic gene functions to cervical cancer. Gynecol. Oncol. 93, 41-48.
29. Jung, H. H., Lee, J., Kim, J. H., Ryu, K. J., Kang, S. A., Park, C., Sung, K., Nam, D. H., Kang, W. K., Park, K. and Im, Y. H. (2005) STAT1 and Nmi are downstream targets of Ets-1 transcription factor in MCF-7 human breast cancer cell. FEBS Lett. 579, 3941-3946.
30. Dombkowski, A. A., Cukovic, D. and Novak, R. F. (2005) Secretome analysis of microarray data reveals extracellular events associated with proliferative potential in a cell line model of breast disease. Cancer Lett. Nov. 16; [Epub ahead of print].
31. Hayashi, J., Stoyanova, R. and Seeger, C. (2005) The transcriptome of HCV replicon expressing cell lines in the presence of alpha interferon. Virology 335, 264-275.
32. Stojdl, D. F., Lichty, B. D., tenOever, B. R., Paterson, J. M., Power, A. T., Knowles, S., Marius, R., Reynard, J., Poliquin, L., Atkins, H., Brown, E. G., Durbin, R. K., Durbin, J. E., Hiscott, J. and Bell, J. C. (2003) VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents. Cancer Cell 4, 263-275.
33. Pascal, T., Debacq-Chainiaux, F., Chretien, A., Bastin, C., Dabee, A. F., Bertholet, V., Remacle, J. and Toussaint, O. (2005) Comparison of replicative senescence and stress-induced premature senescence combining differential display and low-density DNA arrays. FEBS Lett. 579, 3651-3659.
34. Kang, M. K., Kameta, A., Shin, K. H., Baluda, M. A., Kim, H. R. and Park, N. H. (2003) Senescence-associated genes in normal human oral keratinocytes. Exp. Cell Res. 287, 272-281.
35. Dimri, G. P. (2005) What has senescence got to do with cancer? Cancer Cell 7, 505-512.
36. Horrevoets, A. J., Fontijn, R. D., van Zonneveld, A. J., de Vries, C. J., ten Cate, J. W. and Pannekoek, H. (1999) Vascular endothelial genes that are responsive to tumor necrosis factor-alpha in vitro are expressed in atherosclerotic lesions, including inhibitor of apoptosis protein-1, stannin, and two novel genes. Blood 93, 3418-3431.
37. Sana, T. R., Janatpour, M. J., Sathe, M., McEvoy, L. M. and McClanahan, T. K. (2005) Microarray analysis of primary endothelial cells challenged with different inflammatory and immune cytokines. Cytokine 29, 256-269.
38. Matsuda, A., Suzuki, Y., Honda, G., Muramatsu, S., Matsuzaki, O., Nagano, Y., Doi, T., Shimotohno, K., Harada, T., Nishida, E., Hayashi, H. and Sugano, S. (2003) Large-scale identification and characterization of human genes that activate NF-kappaB and MAPK signaling pathways. Oncogene 22, 3307-3318.
39. Mimmack, M. L., Ryan, M., Baba, H., Navarro-Ruiz, J., Iritani, S., Faull, R. L., McKenna, P. J., Jones, P. B., Arai, H., Starkey, M., Emson, P. C. and Bahn, S. (2002) Gene expression analysis in schizophrenia: reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22. Proc. Natl. Acad. Sci. USA 99, 4680-4685.
40. Carmeliet, P. (2005) Angiogenesis in life, disease and medicine. Nature 438, 932-936.
41. Gerber, H. P., Dixit, V. and Ferrara, N. (1998) Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J. Biol. Chem. 273, 13313-13316.
42. Pollman, M. J., Naumovski, L. and Gibbons, G. H. (1999) Endothelial cell apoptosis in capillary network remodeling. J. Cell. Physiol. 178, 359-370.
43. Almawi, W. Y., Melemedjian, O. K. and Jaoude, M. M. (2004) On the link between Bcl-2 family proteins and glucocorticoid-induced apoptosis. J. Leukoc. Biol. 76, 7-14.
44. Jaattela, M. and Tschopp, J. (2003) Caspase-independent cell death in T lymphocytes. Nat. Immunol. 4, 416-423.
45. Galon, J., Franchimont, D., Hiroi, N., Frey, G., Boettner, A., Ehrhart-Bornstein, M., O'Shea, J. J., Chrousos, G. P. and Bornstein, S. R. (2002) Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J. 16, 61-71.
46. Zhao, M., Eaton, J. W. and Brunk, U. T. (2001) Bcl-2 phosphorylation is required for inhibition of oxidative stress-induced lysosomal leak and ensuing apoptosis. FEBS Lett. 509, 405-412.
47. Chen, R., Valencia, I., Zhong, F., McColl, K. S., Roderick, H. L., Bootman, M. D., Berridge, M. J., Conway, S. J., Holmes, A. B., Mignery, G. A., Velez, P. and Distelhorst, C. W. (2004) Bcl-2 functionally interacts with inositol 1,4,5-trisphosphate receptors to regulate calcium release from the ER in response to inositol 1,4,5-trisphosphate. J. Cell Biol. 166, 193-203.
48. Yuan, X. M., Li, W., Dalen, H., Lotem, J., Kama, R., Sachs, L. and Brunk, U. T. (2002) Lysosomal destabilization in p53-induced apoptosis. Proc. Natl. Acad. Sci. USA 99, 6286-6291.
49. Boya, P., Andreau, K., Poncet, D., Zamzami, N., Perfettini, J. L., Metivier, D., Ojcius, D. M., Jaattela, M. and Kroemer, G. (2003) Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion. J. Exp. Med. 197, 1323-1334.
50. Kagedal, K., Johansson, A. C., Johansson, U., Heimlich, G., Roberg, K., Wang, N. S., Jurgensmeier, J. M. and Ollinger, K. (2005) Lysosomal membrane permeabilization during apoptosis - involvement of Bax? Int. J. Exp. Pathol. 86, 309-321.
51. Bidere, N., Lorenzo, H. K., Carmona, S., Laforge, M., Harper, F., Dumont, C. and Senik, A. (2003) Cathepsin D triggers Bax activation, resulting in selective apoptosis-inducing factor (AIF) relocation in T lymphocytes entering the early commitment phase to apoptosis. J. Biol. Chem. 278, 31401-31411.
52. Boya, P., Gonzalez-Polo, R. A., Poncet, D., Andreau, K., Vieira, H. L., Roumier, T., Perfettini, J. L. and Kroemer, G. (2003) Mitochondrial membrane permeabilization is a critical step of lysosome-initiated apoptosis induced by hydroxychloroquine. Oncogene 22, 3927-3936.
53. Cirman, T., Oresic, K., Mazovec, G. D., Turk, V., Reed, J. C., Myers, R. M., Salvesen, G. S. and Turk, B. (2004) Selective disruption of lysosomes in HeLa cells triggers apoptosis mediated by cleavage of Bid by multiple papain-like lysosomal cathepsins. J. Biol. Chem. 279, 3578-3587.
54. Houseweart, M. K., Vilaythong, A., Yin, X. M., Turk, B., Noebels, J. L. and Myers, R. M. (2003) Apoptosis caused by cathepsins does not require Bid signaling in an in vivo model of progressive myoclonus epilepsy (EPM1). Cell Death Differ 10, 1329-1335.
55. Li, J. H. and Pober, J. S. (2005) The cathepsin B death pathway contributes to TNF plus IFN-gamma-mediated human endothelial injury. J. Immunol. 175, 1858-1866.
56. Werneburg, N., Guicciardi, M. E., Yin, X. M. and Gores, G. J. (2004) TNF-alpha-mediated lysosomal permeabilization is FAN and caspase 8/Bid dependent. Am J Physiol Gastrointest Liver Physiol. 287, G436-443.
57. Xong, H. V., Vanhamme, L., Chamekh, M., Chimfwembe, C. E., Van Den Abbeele, J., Pays, A., Van Meirvenne, N., Hamers, R., De Baetselier, P. and Pays, E. (1998) A VSG expression site-associated gene confers resistance to human serum in Trypanosoma rhodesiense. Cell 95, 839-846.
58. McGhee, K. A., Morris, D. W., Schwaiger, S., Nangle, J. M., Donohoe, G., Clarke, S., Meagher, D., Quinn, J., Scully, P., Waddington, J. L., Gill, M. and Corvin, A. (2005) Investigation of the apolipoprotein-L (APOL) gene family and schizophrenia using a novel DNA pooling strategy for public database SNPs. Schizophr. Res. 76, 231-238.